Feed BMXC
Summary
48 / 100 · Bulios Score
Valuation 100Growth 100Profitability 0Quality 57Debt 0Stability 13
What speaks for it
- Revenue grew by 15% a year over the last 3 years.
- It earns 4,034 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
20222023202420252026
Diluted EPS (USD)
20222023202420252026
Revenue fell by 30% a year over 5 years. Over the last 3 years it grew by 15% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $12.0M.
Profitability in detailIs it financially healthy?
Cash and short-term investments $0.00
Debt $817.2K
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.